Clinical Trial Update: Cyclophosphamide for Hematopoietic Stem Cell Mobilization in Patients With a Hematologic Malignancy [Phase 2]

View source ↗

Summary

Phase 2 trial investigating cyclophosphamide for mobilization of hematopoietic stem cells in patients with hematologic malignancies has completed with posted re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Hematologic Malignancies | Phase 2 | Status: COMPLETED | Results posted: 2021-02-16